US 10676461
Heterocyclic compound
granted A61KA61K31/09A61K31/498
Quick answer
US patent 10676461 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/09, A61K31/498, A61K31/57, A61K31/58